{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:50:44Z","timestamp":1770288644890,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001516","name":"National Heart Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001530","name":"Canterbury Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jchf.2022.11.006","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T17:52:27Z","timestamp":1673459547000},"page":"227-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Augmentation of Natriuretic Peptide Bioactivity via Combined Inhibition of Neprilysin and Phosphodiesterase-9 in Heart Failure"],"prefix":"10.1016","volume":"11","author":[{"given":"Nicola J.A.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-5096","authenticated-orcid":false,"given":"Timothy C.R.","family":"Prickett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam T.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2022.11.006_bib1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction. a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2022.11.006_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/CS20040253","article-title":"Cardiac natriuretic peptides for cardiac health","volume":"108","author":"Rademaker","year":"2005","journal-title":"Clin Sci"},{"key":"10.1016\/j.jchf.2022.11.006_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.15420\/cfr.2016:4:2","article-title":"Current understanding of the compensatory actions of cardiac natriuretic peptides in cardiac failure: a clinical perspective","volume":"2","author":"Lee","year":"2016","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jchf.2022.11.006_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2022.11.006_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jchf.2022.11.006_bib6","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"suppl 1","key":"10.1016\/j.jchf.2022.11.006_bib7","first-page":"P1461","article-title":"Characterisation of myocardial and serum levels of phosphodiesterase 9a in patients with heart failure: relation to left atrial size and right ventricular function","volume":"38","author":"Besler","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2022.11.006_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1365-2362.2003.01222.x","article-title":"Mechanisms of renal hyporesponsiveness to ANP in heart failure","volume":"33","author":"Charloux","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jchf.2022.11.006_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijcard.2004.12.020","article-title":"Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels","volume":"104","author":"Nakajima","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib10","doi-asserted-by":"crossref","first-page":"H33","DOI":"10.1152\/ajpheart.2000.278.1.H33","article-title":"Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs","volume":"278","author":"Lainchbury","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007300","article-title":"CRD-733, a novel PDE9 (phosphodiesterase 9) inhibitor, reverses pressure overload-induced heart failure","volume":"14","author":"Richards","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2022.11.006_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2019.05.067","article-title":"Phosphodiesterase-9 inhibition: integrated hemodynamic, hormonal and renal actions in health and experimental heart failure","volume":"74","author":"Scott","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nature14373","article-title":"Cardiology: a big-hearted molecule","volume":"519","author":"Kuhn","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jchf.2022.11.006_bib14","first-page":"H1052","article-title":"Neurohumoral changes during the onset and offset of ovine heart failure: role of ANP","volume":"256","author":"Fitzpatrick","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib15","first-page":"H1536","article-title":"Urocortin 1 administration from the onset of rapid left ventricular pacing represses progression to overt heart failure","volume":"293","author":"Rademaker","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib16","first-page":"H2372","article-title":"Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure","volume":"273","author":"Rademaker","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib17","first-page":"H2406","article-title":"Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart","volume":"273","author":"Yamamoto","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1573403X15666190625160352","article-title":"Neprilysin: a potential therapeutic target of arterial hypertension?","volume":"16","author":"Salazar","year":"2020","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jchf.2022.11.006_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacc.2016.04.060","article-title":"A\u00a0test in context: neprilysin: function, inhibition, and biomarker","volume":"68","author":"Bayes-Genis","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/j.jchf.2022.11.006_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2019.11.140","article-title":"Preliminary characterization of phosphodiesterase-9 in rodent and human pulmonary artery","volume":"140","author":"Wang","year":"2020","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2022.11.006_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/bph.14621","article-title":"inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial","volume":"176","author":"Hobbs","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jchf.2022.11.006_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/cs0910283","article-title":"Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, hemodynamic and natriuretic responses in ovine heart failure","volume":"91","author":"Rademaker","year":"1996","journal-title":"Clin Sci"},{"key":"10.1016\/j.jchf.2022.11.006_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1152\/advan.00177.2016","article-title":"The renal and cardiovascular effects of natriuretic peptides","volume":"41","author":"Wong","year":"2017","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.jchf.2022.11.006_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0024-3205(88)90113-0","article-title":"lntrarenal localization of degradation of atrial natriuretic peptide in glomeruli and cortical nephron segments","volume":"43","author":"Shima","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.jchf.2022.11.006_bib25","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1074\/jbc.273.25.15553","article-title":"Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases","volume":"273","author":"Soderling","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jchf.2022.11.006_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1523-1755.1999.00233.x","article-title":"Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney","volume":"55","author":"Dousa","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2022.11.006_bib27","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.15420\/cfr.2019.21","article-title":"Neprilysin as a biomarker: challenges and opportunities","volume":"6","author":"Pavo","year":"2020","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jchf.2022.11.006_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.82.1.196","article-title":"Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure","volume":"82","author":"Cavero","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2022.11.006_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1590\/S0004-27302006000200006","article-title":"The broad homeostatic role of natriuretic peptides","volume":"50","author":"Maack","year":"2006","journal-title":"Arq Bras Endocrinol Metab"},{"key":"10.1016\/j.jchf.2022.11.006_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.665831","article-title":"Albuminuria and dipstick proteinuria for predicting mortality in heart failure: a systematic review and meta-analysis","volume":"8","author":"Liang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jchf.2022.11.006_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12933-019-0847-8","article-title":"The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the\u00a0Zucker obese rat","volume":"18","author":"Habibi","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jchf.2022.11.006_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11897-013-0164-6","article-title":"Epidemiology and importance of renal dysfunction in heart failure patients","volume":"10","author":"Giamouzis","year":"2013","journal-title":"Curr Heart Fail Rep"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177922006588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177922006588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:01:53Z","timestamp":1761973313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177922006588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213177922006588"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2022.11.006","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmentation of Natriuretic Peptide Bioactivity via Combined Inhibition of Neprilysin and Phosphodiesterase-9 in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}